Business1 year ago
The Ozempic effect has battered this weight loss stock, but Morgan Stanley says it’s a top pick
[ad_1] Game-changing anti-obesity medications have posed nothing short of an existential crisis for Weight Watchers parent WW International since they arrived on the scene, but CEO...
